myirislogo
05 July, 2015 13:16 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Hindalco In 110.55 0.54
State Bank O 268.85 0.54
Reliance 1006.75 0.35
Tata Stl 300.95 1.13
Icici Bank 314.35 0.45
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Divis Laboratories Limited
Divis Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532488NSE:DIVISLABBloomberg:DIVI@INReuters:DIVI.BO
Market Lot: 1Face Value: 2ISIN Demat: INE361B01024
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
25-MAY-15 Divis Laboratories, a pharmaceutical ingredients and intermediates company, posted a consolidated rise of 17.84% to Rs 2.31 billion in the 26-MAY-14 During the quarter, the profit of the company rose 8.78% to Rs 1,964.30 million from Rs 1,805.70 million in the same quarter previous year. 08-NOV-13 Divis Laboratories, a pharmaceutical ingredients and intermediates company, today reported a rise of 73.71% in its net profit to Rs 2.05...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Emkay downgrades Divis Lab to 'Hold'   -IRIS 13-Aug-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2015 (12)31-Mar-2014 (12)31-Mar-2013(12)
Net sales 30723.0025071.8021239.50
Other Income428.40839.00790.40
Total Income31151.4025910.8022029.90
Cost of goods sold19219.6014951.1013376.70
OPBDIT11931.8010959.708653.20
PAT8470.607917.206114.20
Gross Block---
Equity capital265.50265.50265.50
EPS (Rs.)63.8259.65-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)19.07 - 29.4915.17 - 24.46-
Debt / Equity (x)---
Operating margin (% of OI)38.342.339.3
Net margin (% of OI)27.230.627.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
7-1-77/E/1/303
Divi Towers
Dharam Karan Road
Ameerpet
Hyderabad
Andhra Pradesh-500 016
PHONE
(040) 2378 6300
FAX
(040) 2378 6460
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer